Publications (37) Publications in which a researcher has participated

2019

  1. Accelerated long-term forgetting in resected and seizure-free temporal lobe epilepsy patients

    Cortex, Vol. 110, pp. 80-91

  2. Amylin as a potential link between type 2 diabetes and alzheimer disease

    Annals of Neurology, Vol. 86, Núm. 4, pp. 539-551

  3. BRIVA-LIFE–A multicenter retrospective study of the long-term use of brivaracetam in clinical practice

    Acta Neurologica Scandinavica, Vol. 139, Núm. 4, pp. 360-368

  4. Biomarcadores en gliomas difusos: Del diagnóstico histomolecular a los marcadores circulantes

    Kranion, Vol. 14, Núm. 3, pp. 100-106

  5. Cardiac sympathetic innervation in the MPTP non-human primate model of Parkinson disease

    Clinical Autonomic Research, Vol. 29, Núm. 4, pp. 415-425

  6. Combining gene transfer and nonhuman primates to better understand and treat Parkinson’s disease

    Frontiers in Molecular Neuroscience

  7. Diagnostic challenges in epilepsy

    Revista de Neurologia, Vol. 68, Núm. 6, pp. 255-263

  8. Enfermedades cerebrovasculares. Hemorragia cerebral

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 70, pp. 4075-4084

  9. Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation

    Scientific Reports, Vol. 9, Núm. 1

  10. Erratum: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience (PLoS ONE (2019)14:6 (e0217881)Doi:10.1371/journal.pone.0217881)

    PLoS ONE

  11. Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice

    Neurologia, Vol. 34, Núm. 6, pp. 408-417

  12. Facial solitary morphea profunda presenting with painful trigeminal neuropathy: A case report

    Cephalalgia, Vol. 39, Núm. 4, pp. 564-568

  13. Fisioterapia en cefalea tensional. ¿Debe recomendarse a nuestros pacientes?

    Anales del sistema sanitario de Navarra, Vol. 42, Núm. 1, pp. 119-120

  14. Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings

    Journal of Neurology, Vol. 266, Núm. 10, pp. 2396-2405

  15. Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience

    PLoS ONE, Vol. 14, Núm. 6

  16. Ictus isquémico de causa inhabitual. Trombosis venosa cerebral. Infarto cerebral silente

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 70, pp. 4108-4119

  17. Nanobiotechnology in parkinson’s disease

    Nanobiotechnology in Neurodegenerative Diseases (Springer International Publishing), pp. 177-208

  18. Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

    Nature Medicine, Vol. 25, Núm. 3, pp. 470-476

  19. Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 11, pp. 301-309

  20. Neuroimaging in dementia. Clinical-radiological correlation

    Radiologia, Vol. 61, Núm. 1, pp. 66-81